Insider Trading History of Germain Mark

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Germain Mark since 2007. The trader's CIK number is 1195498. At the time of the last reporting, Germain Mark was the Director of Pluristem Therapeutics Inc. (stock ticker symbol PSTI). Also see all insider trading activities at Pluristem Therapeutics Inc.

Note that in the past GERMAIN MARK also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Pluristem Therapeutics Inc (PSTI) by Germain Mark

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 PSTI 0 $0 69,691 $103,618 0 $0
2014 PSTI 0 $0 111,073 $408,008 0 $0

Yearly summary of insider trading at Reis, Inc. (REIS) by Germain Mark

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 REIS 0 $0 0 $0 214,922 $1,210,482


Insider trading activities at 2 companies by Germain Mark:

1. Pluristem Therapeutics Inc (PSTI)

2. Reis, Inc. (REIS)

Table 1. Insider trading of Pluristem Therapeutics Inc (PSTI) by Germain Mark

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-03-16 PSTI Sale 11,640 1.48 17,227
2018-03-15 PSTI Sale 34,233 1.48 50,664
2018-03-14 PSTI Sale 23,818 1.50 35,727
2014-06-18 PSTI Sale 43,215 3.13 135,219
2014-03-04 PSTI Sale 67,858 4.02 272,789

Table 2. Insider trading of Reis, Inc. (REIS) by Germain Mark

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-12-17 REIS Option Ex 123,452 5.81 717,256
2007-07-02 WRP Option Ex 20,574 5.81 119,534
2007-06-20 WRP Option Ex 70,896 5.27 373,692

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Germain Mark (Director of Pluristem Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.